Adenosine A2B receptor antagonist suppresses differentiation to regulatory T cells without suppressing activation of T cells

Hiroko Nakatsukasa, Mitsutoshi Tsukimoto, Hitoshi Harada, Shuji Kojima

研究成果: Article査読

20 被引用数 (Scopus)

抄録

Extracellular adenosine activates P1 receptors (A1, A2A, A2B, A3) on cellular membranes. Here, we investigated the involvement of P1 receptor-mediated signaling in differentiation to regulatory T cells (Treg). Treg were induced in vitro by incubating isolated CD4+CD62L+ naïve murine T cells under Treg-skewing conditions. Antagonists of A1 and A2B receptors suppressed the expression of Foxp3, a specific marker of Treg, and the production of IL-10, suggesting the involvement of A1 and A2B receptors in differentiation to Treg. We also investigated the effect of these antagonists on T cell activation, which is essential for differentiation to Treg, and found that A1 antagonist, but not A2B antagonist, suppressed T cell activation. We conclude that A1 and A2B receptors are both involved in differentiation to Treg, but through different mechanisms. Since A2B antagonist blocked differentiation to Treg without suppressing T cell activation, it is possible that blockade of A2B receptor would facilitate tumor immunity.

本文言語English
ページ(範囲)114-119
ページ数6
ジャーナルBiochemical and Biophysical Research Communications
409
1
DOI
出版ステータスPublished - 2011 5月 27
外部発表はい

ASJC Scopus subject areas

  • 生物理学
  • 生化学
  • 分子生物学
  • 細胞生物学

フィンガープリント

「Adenosine A2B receptor antagonist suppresses differentiation to regulatory T cells without suppressing activation of T cells」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル